4ok5: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{STRUCTURE_4ok5| PDB=4ok5 | SCENE= }} | |||
===Crystal Structure of Hepatitis C Virus NS3 Helicase Inhibitor Co-complex with Compound 9 [1-(3-ethynylbenzyl)-1H-indol-3-yl]acetic acid]=== | |||
{{ABSTRACT_PUBMED_24467709}} | |||
==About this Structure== | |||
[[4ok5]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4OK5 OCA]. | |||
==Reference== | |||
<ref group="xtra">PMID:024467709</ref><references group="xtra"/><references/> | |||
[[Category: Padyana, A K.]] | |||
[[Category: Atpase]] | |||
[[Category: Hepatitis]] | |||
[[Category: Hydrolase-hydrolase inhibitor complex]] | |||
[[Category: Ns3 helicase]] | |||
[[Category: Ntpase]] | |||
Revision as of 10:43, 2 April 2014
Crystal Structure of Hepatitis C Virus NS3 Helicase Inhibitor Co-complex with Compound 9 [1-(3-ethynylbenzyl)-1H-indol-3-yl]acetic acid]Crystal Structure of Hepatitis C Virus NS3 Helicase Inhibitor Co-complex with Compound 9 [1-(3-ethynylbenzyl)-1H-indol-3-yl]acetic acid]
Template:ABSTRACT PUBMED 24467709
About this StructureAbout this Structure
4ok5 is a 2 chain structure. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Laplante SR, Padyana AK, Abeywardane A, Bonneau P, Cartier M, Coulombe R, Jakalian A, Wildeson-Jones J, Li X, Liang S, McKercher G, White P, Zhang Q, Taylor SJ. Integrated strategies for identifying leads that target the NS3 helicase of the hepatitis C virus. J Med Chem. 2014 Mar 13;57(5):2074-90. doi: 10.1021/jm401432c. Epub 2014 Jan 27. PMID:24467709 doi:http://dx.doi.org/10.1021/jm401432c